Mild Serotonin Syndrome on Fluvoxamine

References

• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth edition (DSM-1V). American Psychiatric Association, Washington, D.C 1994
   Google Scholar
• Baetz M., Malcolm D. Serotonin syndrome from fluvoxamine and buspirone. Canadian Journal of Psychiatry 1995; 40: 428–429
   Google Scholar
• Bastani J. B., Troester M. M., Bastani A. J. Serotonin syndrome and fluvoxamine: a case study. Nebraska Medical Journal 1996; 81: 107–109
   Google Scholar
• Baumann P. Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors. Clinical Pharmacokinetics 1996; 31: 444–469
   PubMed Web of Science ®Google Scholar
• Brown T. M., Skop B. P., Mareth T. R. Pathophysiology and management of the serotonin syndrome. Annals of Pharmacotherapy 1996; 30: 527–533
   PubMed Web of Science ®Google Scholar
• Claassen V. Review of the animal pharmacology and pharmacokinetics of fluvoxamine. British Journal of Clinical Pharmacology 1983; 15: 349S–355S, (Suppl. 3)
   PubMed Web of Science ®Google Scholar
• De Wilde J. E., Mertens C., Wakelin J. S. Clinical trials of fluvoxamine vs. chlorimipramine with single and three times daily dosing. British Journal of Clinical Pharmacology 1983; 15: 427S–431S, (Suppl. 3)
   PubMed Web of Science ®Google Scholar
• Dick P., Ferrero E. A double-blind comparative study of the clinical efficacy of fluvoxamine and chlorimipramine. British Journal of Clinical Pharmacology 1983; 15: 419S–425S, (Suppl. 3)
   Google Scholar
• Ebert D., Albert R., May A., Merz A., Murata H., Stosiek I., Zahner B. The serotonin syndrome and psychosis-like side-effects of fluvoxamine clinical use - an estimation of incidence. European Neuropsychopharmacology 1997; 7: 71–74
   Google Scholar
• Fischer P. Serotonin syndrome in the elderly after antidepressive monotherapy. Journal of Clinical Psychopharmacology 1995; 15: 440–442
   PubMedGoogle Scholar
• Gill M., LoVecchio F., Selden B. Serotonin syndrome in a child after a single dose of fluvoxamine. Annals of Emergency Medicine 1999; 33: 457–459
   PubMed Web of Science ®Google Scholar
• Hegerl U., Bottlender R., Gallinat J., Kuss H. J., Ackenheil M., Moller H. J. The serotonin syndrome scale: first results on validity. European Archives of Psychiatry and Clinical Neuroscience 1998; 248: 96–103
   PubMed Web of Science ®Google Scholar
• Ishigooka J., Wakatabe H., Shimada E., Suzuki M., Fukuyama Y., Murasaki M., Miura S. Phase I trial on the serotonin reuptake inhibitor SME3110 (fluvoxamine maleate) (in Japanese). Rinsho Hyoka (Clinical Evaluation) 1993; 21: 441–490
   Google Scholar
• Kaneda Y., Ohmori T., Fujii A. The serotonin syndrome: investigation using the Japanese version of the Serotonin Syndrome Scale (JSSS). Psychiatry Research, (in press).
   Google Scholar
• Kaneda Y., Ohmori T., Hegerl U. The Japanese version of the Serotonin Syndrome Scale (JSSS) (in Japanese). No To Shinkei (Brain and Nerve) 2000; 52: 507–510
   Google Scholar
• Kudo K., Sasaki I., Akiyoshi J., Tsuchiyama K., Katsuragi S., Fujii I. Serotonin syndrome; investigation among tricyclic antidepressants (in Japanese). Seishin Igaku (Clinical Psychiatry) 1997a; 39: 757–759
   Google Scholar
• Kudo K., Sasaki I., Tsuchiyama K., Akiyoshi J., Nagayama H., Fujii I. Serotonin syndrome during clomipramine monotherapy: comparison of two diagnostic criteria. Psychiatry and Clinical Neurosciences 1997b; 51: 43–46
   Google Scholar
• Lane R., Baldwin D. Selective serotonin reuptake inhibitor-induced serotonin syndrome: review. Journal of Clinical Psychopharmacology 1997; 17: 208–221
   PubMed Web of Science ®Google Scholar
• Lejoyeux M., Fineyre F., Adès J. The serotonin syndrome. American Journal of Psychiatry 1992; 149: 1410–1411
   PubMed Web of Science ®Google Scholar
• Lejoyeux M., Rouillon F., Adès J. Prospective evaluation of the serotonin syndrome in depressed inpatients treated with clomipramine. Ada Psychiatrka Scandinavica 1993; 88: 369–371
   Google Scholar
• Lenzi A., Raffaclli S., Marazziti D. Serotonin syndrome-like symptoms in a patient with obsessive-compulsive disorder, following inappropriate increase in fluvoxamine dosage. Pharmacopsychiatry 1993; 26: 10–101
   Google Scholar
• Öhman R., Spigset O. Serotonin syndrome induced by fluvoxamine-lithium interaction. Pharmacopsychiatry 1993; 26: 263–264
   PubMed Web of Science ®Google Scholar
• Spigset O. Adverse reactions of selective serotonin reuptake inhibitors: reports from a spontaneous reporting system. Drug Safety 1999; 20: 277–287
   PubMed Web of Science ®Google Scholar
• Sporer K. A. The serotonin syndrome. Implicated drugs, pathophysiology and management. Drug Safety 1995; 13: 94–104
   PubMedGoogle Scholar
• Sternbach H. The serotonin syndrome. American Journal of Psychiatry 1991; 148: 705–713
   PubMed Web of Science ®Google Scholar
• Wagner W., Plekkenpol B., Gray T. E., Vlaskamp H., Essers H. Safety database on fluvoxamine: analysis and report. Pharmacopsychiatry 1993; 26: 10–16, (Suppl. I)
   Google Scholar
• Wagner W., Vause E. W. Fluvoxamine. A review of global drug-drug interaction data. Clinical Pharmacokinetics 1995; 29: 26–31, (Suppl. 1)
   PubMedGoogle Scholar
• Wagner W., Zaborny B. A., Gray T. E. Fluvoxamine. A review of its safety profile in world-wide studies. International Clinical Psychopharmacology 1994; 9: 223–227
   Google Scholar
• Ware M. R. Fluvoxamine: a review of the controlled trials in depression. Journal of Clinical Psychiatry 1997; 58: 15–23, (Suppl. 5)
   Google Scholar